Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 1427 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Vasopressin receptor antagonists and their role in clinical medicine

Narayen Girish, Mandal Surya Narayan

Year : 2012| Volume: 16| Issue : 2 | Page no: 183-191

   This article has been cited by
1 Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience
Gun Ha Park,Chang Min Lee,Jae Won Song,Moon Chan Jung,Jwa Kyung Kim,Young Rim Song,Hyung Jik Kim,Sung Gyun Kim
The Korean Journal of Internal Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 The differential effects of systemic vasoconstrictors on human pulmonary artery tension†
Azar Hussain,Rob Bennett,Yama Haqzad,Syed Qadri,Mubarak Chaudhry,Michael Cowen,Mahmoud Loubani,Alyn Morice
European Journal of Cardio-Thoracic Surgery. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 Ligand recognition properties of the vasopressin V2 receptor studied under QSAR and molecular modeling strategies
Marlet Martínez-Archundia,Brenda Colín-Astudillo,Liliana M. Moreno-Vargas,Guillermo Ramírez-Galicia,Ramón Garduño-Juárez,Omar Deeb,Martha Citlalli Contreras-Romo,Andres Quintanar-Stephano,Edgar Abarca-Rojano,José Correa-Basurto
Chemical Biology & Drug Design. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells—a Potential Target for Pharmacological Intervention in Cardiovascular Diseases
Tanja Vukicevic,Maike Schulz,Dörte Faust,Enno Klussmann
Frontiers in Pharmacology. 2016; 7
[Pubmed]  [Google Scholar] [DOI]
5 Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema
Yasunari Hiramine,Hirofumi Uto,Yasushi Imamura,Takuya Hiwaki,Takeshi Kure,Sho Ijuin,Kohei Oda,Seiichi Mawatari,Kotaro Kumagai,Koki Tokunaga,Hirofumi Higashi,Ichiro Kanetsuki,Osamu Kubozono,Shigeho Maenohara,Akio Ido
Hepatology Research. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 Efficacy and safety of tolvaptan in hospitalised patients: a single-centre experience
J. R. Ramos,M. M. Hernandez,M. D. E. Solsona,P. M. Alvarez,I. F. Noguera,J. L. P. Andres
European Journal of Hospital Pharmacy: Science and Practice. 2015; 22(1): 28
[Pubmed]  [Google Scholar] [DOI]
7 Molecular basis of pharmacological therapy in Cushing’s disease
Diego Ferone,Claudia Pivonello,Giovanni Vitale,Maria Chiara Zatelli,Annamaria Colao,Rosario Pivonello
Endocrine. 2013;
[Pubmed]  [Google Scholar] [DOI]


Read this article